K-Ion 10mg Tablet contains Nicorandil 10mg, a vasodilatory agent used primarily in the management of angina pectoris. Nicorandil acts through dual mechanisms: it functions as a nitrate donor, releasing nitric oxide which induces vasodilation of large coronary arteries, and as an ATP-sensitive potassium channel opener, leading to relaxation of vascular smooth muscle in both arterial and venous beds. This dual action results in reduced myocardial oxygen demand by decreasing preload and afterload, thereby improving coronary blood flow and alleviating anginal symptoms. K-Ion is indicated for the prophylactic treatment of chronic stable angina and may be used when conventional anti-anginal therapies are insufficient or contraindicated. The recommended dosage should be individualized based on clinical response and tolerability, with careful monitoring for potential adverse effects such as headache, dizziness, flushing, and gastrointestinal disturbances. Caution is advised in patients with hypotension, severe hepatic or renal impairment, and those concurrently using other vasodilators or phosphodiesterase inhibitors. K-Ion should be administered under medical supervision, ensuring appropriate assessment of cardiovascular status and adherence to prescribed dosing to optimize therapeutic outcomes and minimize risks.